keyword
https://read.qxmd.com/read/37173928/resection-of-skin-cancer-resulting-in-free-vascularized-tissue-reconstruction-always-a-therapeutic-failure
#21
JOURNAL ARTICLE
Tina Rauchenwald, Angela Augustin, Theresa B Steinbichler, Bernhard W Zelger, Gerhard Pierer, Matthias Schmuth, Dolores Wolfram, Evi M Morandi
The globally increasing incidence of cutaneous malignancies leads, in parallel, to increasing numbers of locally advanced skin cancer resulting in reconstructive surgery. Reasons for locally advanced skin cancer may be a patient's neglect or aggressive tumor growth, such as desmoplastic growth or perineural invasion. This study investigates characteristics of cutaneous malignancies requiring microsurgical reconstruction with the aim of identifying possible pitfalls and improving diagnostic and therapeutic processes...
April 25, 2023: Cancers
https://read.qxmd.com/read/37153950/dramatic-response-of-face-desmoplastic-melanoma-after-two-doses-of-immunotherapy
#22
JOURNAL ARTICLE
Marco Rubatto, Federica Gelato, Paolo Broganelli, Paolo Fava, Rebecca Senetta, Gianluca Avallone, Luca Mastorino, Damiano Grandinetti, Simone Ribero, Pietro Quaglino
No abstract text is available yet for this article.
April 2023: Italian journal of dermatology and venereology
https://read.qxmd.com/read/37071762/single-agent-pd-1-blockade-is-treatment-of-choice-for-desmoplastic-melanoma
#23
JOURNAL ARTICLE
(no author information available yet)
Data from the phase II S1512 trial indicate that patients with inoperable metastatic desmoplastic melanoma are highly responsive to first-line pembrolizumab. As such, anti-PD-1 monotherapy, rather than current combinations such as nivolumab-relatlimab, should be considered for these patients.
April 18, 2023: Cancer Discovery
https://read.qxmd.com/read/36928737/top-10-differential-diagnoses-for-desmoplastic-melanoma
#24
REVIEW
Angel Fernandez-Flores, Rajendra Singh, David S Cassarino
BACKGROUND: Desmoplastic melanoma is a rare subtype of melanoma mainly appearing on sun-exposed skin. Clinically, it is many times non-pigmented and therefore the diagnosis is often not suspected. METHODS: Review article. RESULTS: In this paper we review the main histopathological, immunohistochemical, and molecular features of desmoplastic melanoma, as well as the top 10 morphologic differential diagnoses which should be considered in most cases...
March 2023: Head and Neck Pathology
https://read.qxmd.com/read/36857167/local-recurrence-rates-after-excision-of-desmoplastic-melanoma-a-systematic-review-and-meta-analysis
#25
JOURNAL ARTICLE
Nina A Ran, Surya Veerabagu, Christopher J Miller, Rosalie Elenitsas, Emily Y Chu, Aimee E Krausz
BACKGROUND: Few prospective studies have evaluated local recurrence rates (LRR) after excision of desmoplastic melanoma (DM); however, several retrospective studies have reported high LRR. OBJECTIVE: To determine LRR after excision of DM and evaluate factors affecting LRR. MATERIALS AND METHODS: Systematic review of the PubMed, Embase, and Web of Science databases was performed to identify studies reporting local recurrence after excision of DM with conventional wide local excision (WLE), Mohs micrographic surgery (MMS), or staged excision (SE)...
March 1, 2023: Dermatologic Surgery: Official Publication for American Society for Dermatologic Surgery [et Al.]
https://read.qxmd.com/read/36828958/long-term-outcomes-of-margin-controlled-excision-for-eyelid-melanoma
#26
JOURNAL ARTICLE
John C Bladen, Raman Malhotra, Andre Litwin
OBJECTIVES: To provide evidence for long-term outcomes for margin-controlled excision of eyelid melanoma. METHODS: Retrospective single-centre observational case series of patients treated for eyelid melanoma between 2007 and 2016, with a minimum of 5-year follow-up. Tumour excision involved rush-paraffin en face horizontal sections and delayed repair (Slow Mohs; SM). RESULTS: Twenty-two cases were seen with a survival of 91% (two deaths from nodular and lentigo maligna melanoma) and seven with melanoma in situ (MIS)...
February 24, 2023: Eye
https://read.qxmd.com/read/36775447/l1cam-and-laminin-vascular-network-association-with-the-high-risk-replacement-histopathologic-growth-pattern-in-uveal-melanoma-liver-metastases
#27
JOURNAL ARTICLE
Raymond Barnhill, Steven van Laere, Peter Vermeulen, Sergio Roman-Roman, Sophie Gardrat, Samar Alsafadi, Malcy Tarin, Gabriel Champenois, André Nicolas, Alexandre Matet, Nathalie Cassoux, Vincent Servois, Manuel Rodrigues, Richard Scolyer, Alexander Lazar, Emanuela Romano, Sophie Piperno-Neumann, Pascale Mariani, Claire Lugassy
The replacement histopathologic growth pattern (rHGP) in melanoma liver metastases connotes an aggressive phenotype (vascular co-option; angiotropic extravascular migratory spread) and adverse prognosis. Herein, replacement and desmoplastic HGP (dHGP) were studied in uveal melanoma liver metastases (MUM). In particular, L1CAM and a "laminin vascular network" were detected at the advancing front of 14/20 cases (p = 0.014) and 16/20 cases (p = 6.4e-05) rHGPs, respectively, but both were absent in the dHGP (8/8 cases) (p = 0...
November 2022: Laboratory Investigation; a Journal of Technical Methods and Pathology
https://read.qxmd.com/read/36751182/difficulty-in-diagnosing-rare-cardiac-tumors-a-case-series
#28
Jiaxi Dong, Ling Wang, Joseph Salvatore, Michelle W Lau
Primary cardiac tumors are rare because metastatic lesions from distant sites account for most masses. We are reporting two cases of malignant intracardiac masses with their diagnostic dilemma. Our first patient is a 72-year-old male with a pertinent history of desmoplastic and spindle cell melanoma who presented after his surveillance positron emission tomography (PET) scan showed a hypermetabolic lesion in the inferior pericardium. The initial impression for this mass is recurrent malignant melanoma. After an initial negative endometrial biopsy, the patient underwent debulking surgery, and pathology revealed high-grade spindle cell sarcoma...
January 2023: Curēus
https://read.qxmd.com/read/36653238/interobserver-agreement-in-the-histopathological-classification-of-desmoplastic-melanomas
#29
JOURNAL ARTICLE
Cecilia Lezcano, Marianne Berwick, Li Luo, Raymond Barnhill, Lyn M Duncan, Pedram Gerami, Lori Lowe, Jane L Messina, Richard A Scolyer, Benjamin Wood, Iwei Yeh, Artur Zembowicz, Klaus J Busam
Desmoplastic melanoma is a subtype of melanoma characterised by amelanotic fusiform melanocytes dispersed in a collagenous stroma. Cell-poor and fibrous stroma-rich 'pure' variants have been distinguished from 'mixed' variants with areas of higher cell density and/or less desmoplastic stroma. This distinction is relevant because patients whose tumours display a pure phenotype have a lower risk for regional lymph node metastasis and distant recurrence. However, little is known about interobserver agreement among pathologists in the subclassification of desmoplastic melanoma...
January 2, 2023: Pathology
https://read.qxmd.com/read/36647746/the-changing-epidemiology-of-desmoplastic-melanoma
#30
JOURNAL ARTICLE
Tricia Tay, Martin G Cook, Kyoko Miura, Megan Grant, Richard Marais, Adele Green
No abstract text is available yet for this article.
January 17, 2023: Acta Dermato-venereologica
https://read.qxmd.com/read/36646575/representativeness-of-initial-skin-biopsies-showing-pure-desmoplastic-melanoma-implications-for-management
#31
JOURNAL ARTICLE
R V Rawson, I A Vergara, J R Stretch, R P M Saw, J F Thompson, S N Lo, R A Scolyer, K J Busam
Desmoplastic melanoma (DM) is an uncommon subtype of melanoma with distinct clinicopathological features. It is classified into pure desmoplastic melanoma (PDM) when the proportion of desmoplastic melanoma is ≥90% of the dermally-invasive component, and mixed desmoplastic melanoma (MDM) when the proportion of desmoplastic melanoma is <90%. Studies have reported a lower sentinel lymph node biopsy (SLNB)-positivity rate in PDM compared to MDM and non-DM. As a result, some have recommended not performing SLNB in PDM patients...
January 6, 2023: Pathology
https://read.qxmd.com/read/36632563/tertiary-lymphoid-structures-in-desmoplastic-melanoma-have-increased-lymphocyte-density-lymphocyte-proliferation-and-immune-cross-talk-with-tumor-when-compared-to-non-desmoplastic-melanomas
#32
JOURNAL ARTICLE
Nicole L Edmonds, Sarah E Gradecki, Priya Katyal, Kevin T Lynch, Anne M Stowman, Alejandro A Gru, Victor H Engelhard, Craig L Slingluff, Ileana S Mauldin
Tertiary lymphoid structures (TLS) are ectopic lymphoid structures that can arise in human cancers and are associated with improved overall survival (OS) and response to immune checkpoint blockade (ICB) in several cancers, including non-desmoplastic metastatic melanoma (NDMM). Desmoplastic melanoma (DM) has one of the highest response rates to ICB, and we previously identified that primary DM (PDM) contains TLS. Despite the association of TLS with survival and ICB response, it is unknown whether TLS or associated markers of immune activity can differ between PDM and NDMM...
2023: Oncoimmunology
https://read.qxmd.com/read/36515639/neurotropic-melanoma-arising-from-a-neurocristic-hamartoma
#33
Stephanie Ann Clements, Benjamin Franklin Kelley, Louis Rivera, Hubert T Greenway
Neurotropic melanoma is a rare type of malignant melanoma with nerve invasion or neural differentiation. Neurocristic cutaneous hamartoma is a rare, benign tumor of the skin and superficial soft tissue that arises from atypical migration of neural crest cells. We report a rare case of a 74-year-old man with a clinically diagnosed giant congenital nevus of the right mid-back, histopathologically confirmed to be a neurocristic cutaneous hamartoma who developed neurotropic spindle cell melanoma within the lesion...
December 14, 2022: Journal of Cutaneous Pathology
https://read.qxmd.com/read/36509217/melanomas-in-children-and-adolescents-clinicopathologic-features-and-survival-outcomes
#34
JOURNAL ARTICLE
Mary-Ann El Sharouni, Robert V Rawson, Alison J Potter, Elizabeth C Paver, James S Wilmott, Arjen J Witkamp, Vigfús Sigurdsson, Paul J van Diest, Richard A Scolyer, John F Thompson, Serigne N Lo, Carla H van Gils
BACKGROUND: Melanomas in the first 2 decades of life are uncommon and poorly understood. OBJECTIVE: To assess clinicopathologic features and survival of children (≤11 years) and adolescents (12-19 years) diagnosed with melanoma. METHODS: A pooled cohort of 514 patients was analyzed (397 Dutch, 117 Australian; 62 children, 452 adolescents). Pathology reports were reevaluated to determine melanoma subtypes. Multivariable Cox models were generated for recurrence-free survival (RFS) and overall survival (OS)...
March 2023: Journal of the American Academy of Dermatology
https://read.qxmd.com/read/36420154/integrative-analysis-deciphers-the-heterogeneity-of-cancer-associated-fibroblast-and-implications-on-clinical-outcomes-in-ovarian-cancers
#35
JOURNAL ARTICLE
Yan Zhao, Song Mei, Yixuan Huang, Junru Chen, Xinlei Zhang, Peng Zhang
Accumulating evidence has recognized that cancer-associated fibroblasts (CAFs) are major players in the desmoplastic stroma of ovarian cancer, modulating tumor progression and therapeutic response. However, it is unclear regarding the signatures of CAFs could be utilized to predict the clinical outcomes of ovarian cancer patients. To fill in this gap, we explored the intratumoral compartment of ovarian cancer by analyzing the single-cell RNA-sequencing (scRNA-seq) datasets of ovarian carcinoma samples, and identified two distinct CAFs (tumor-promoting CAF_c1 subtype and myofibroblasts-like CAF_c2 subtype)...
2022: Computational and Structural Biotechnology Journal
https://read.qxmd.com/read/36383901/next-generation-sequencing-as-a-potential-diagnostic-adjunct-in-distinguishing-between-desmoplastic-melanocytic-neoplasms
#36
JOURNAL ARTICLE
Andrew Roth, Anastasiya Boutko, Nathaniel Lampley, Soneet Dhillon, Michael Hagstrom, Shantel Olivares, David Dittman, Lawrence Jennings, Lucas Santana Dos Santos, Klaus Busam, Pedram Gerami
Desmoplastic melanomas (DMs) are often challenging to diagnose and ancillary tests, such as immunohistochemistry, have limitations. One challenge is distinguishing DM from benign desmoplastic melanocytic neoplasms. In this study, we explored the utility of next-generation sequencing data in the diagnosis of DMs versus desmoplastic Spitz nevi (DSN) and desmoplastic nevi (DN). We sequenced 47 cases and retrieved 12 additional previously sequenced clinical cases from our dermatopathology database. The 59 total cases were comprised of 21 DMs, 25 DSN, and 13 DN...
March 1, 2023: American Journal of Surgical Pathology
https://read.qxmd.com/read/36283925/sentinel-lymph-node-biopsy-in-desmoplastic-melanoma-the-percent-desmoplastic-component-matters-a-systematic-review
#37
JOURNAL ARTICLE
Meghan Hodson, Paul Feustel, Lindy Davis
BACKGROUND: Desmoplastic melanoma (DM) is a less common form of cutaneous melanoma that has been described for decades; however, controversy remains regarding the management and use of sentinel lymph node biopsy (SLNB). The purpose of this study is to identify whether SLNB is indicated in all cases of DM, including the pure subtype. METHODS: A systematic review was conducted using PubMed (with access to MEDLINE) along with the Cochrane Central Register of Controlled Trials from 2001 to 2019...
December 2022: Journal of Plastic, Reconstructive & Aesthetic Surgery: JPRAS
https://read.qxmd.com/read/36254545/from-morphea-to-dermatofibrosarcoma-protuberans
#38
JOURNAL ARTICLE
Iva Crnarić, Mirna Šitum, Marija Delaš Aždajić, Majda Vučić, Marija Buljan
Dear Editor, Morphea profunda (MP) is a chronic autoimmune disease, a subtype of localized scleroderma that presents clinically as local discomfort due to the impairment of skin motility (1). Dermatofibrosarcoma protuberans (DFSP) is a rare soft tissue neoplasm that not only infiltrates the dermis and subcutaneous tissue, but can also affect the muscles and bones with finger-like extensions, usually present on the trunk and the proximal extremities (2). DFSP is known for its indolent clinical course, locally aggressive behavior, and high local recurrence rates, but relatively low risk of metastatic spread (2)...
September 2022: Acta Dermatovenerologica Croatica: ADC
https://read.qxmd.com/read/36200756/prame-is-a-useful-marker-for-the-differential-diagnosis-of-melanocytic-tumours-and-histological-mimics
#39
JOURNAL ARTICLE
Yan-Ping Chen, Wen-Wen Zhang, Ya-Ting Qiu, Long-Feng Ke, Hao Chen, Gang Chen
AIMS: Although the morphological assessment of melanoma is generally straightforward, diagnosis can be especially difficult when the significant morphological and immunohistochemical results overlap with those of benign and malignant melanocytic tumours and histological mimics. This study assessed the potential diagnostic utility of measuring PReferentially expressed Antigen in MElanoma (PRAME) immunohistochemically in naevi, melanomas and clear cell sarcomas (CCSs) in Chinese patients...
January 2023: Histopathology
https://read.qxmd.com/read/36140597/prame-immunoexpression-in-275-cutaneous-melanocytic-lesions-a-double-institutional-experience
#40
JOURNAL ARTICLE
Gerardo Cazzato, Eliano Cascardi, Anna Colagrande, Vincenzo Belsito, Lucia Lospalluti, Caterina Foti, Francesca Arezzo, Miriam Dellino, Nadia Casatta, Carmelo Lupo, Luigi Buongiorno, Alessandra Stellacci, Maricla Marrone, Giuseppe Ingravallo, Eugenio Maiorano, Leonardo Resta
In recent years, the preferentially expressed antigen in melanoma (PRAME) has also been used in the histopathological diagnosis of melanocytic lesions, in order to understand if it could constitute a valid, inexpensive, and useful resource in dermatopathological fields. We performed a double-center study to evaluate whether the data on the usefulness and possible limitations of PRAME could also be confirmed by our group. From 1 December 2021 to 29 March 2022, we collected 275 cases of melanocytic lesions that were immunostained with PRAME (Ab219650) and rabbit monoclonal antibody (Abcam)...
September 9, 2022: Diagnostics
keyword
keyword
84990
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.